Clover Health Posts First GAAP Profit in Q1 2026 Amid Medicare Advantage Growth

  • Clover Health reported $27 million in GAAP net income for Q1 2026, a $29 million year-over-year improvement.
  • Medicare Advantage membership grew 51% year-over-year to 155,773 members.
  • Total revenues increased 62% year-over-year to $749 million.
  • Adjusted EBITDA rose 56% year-over-year to $40 million.
  • Company reaffirmed full-year 2026 guidance, targeting $0–$20 million in GAAP net income.

Clover Health's first GAAP profitable quarter signals a potential turning point for the company, which has been investing heavily in its technology platform to drive efficiency and better health outcomes. The 51% year-over-year growth in Medicare Advantage membership underscores the demand for its wide-network PPO plans, but maintaining profitability will require careful cost management as the company scales. The healthcare technology sector is increasingly focused on data-driven solutions, and Clover Health's ability to leverage its platform could set it apart from competitors.

Sustainability of Profitability
Whether Clover Health can maintain GAAP profitability through the rest of 2026 amid rising healthcare costs and competitive pressures.
Technology Scaling
The pace at which Clover Assistant can expand its impact on clinical outcomes and cost management across the growing member base.
Regulatory Compliance
How evolving Medicare Advantage regulations may affect Clover Health's operations and financial performance.